SLC9A9 and myeloid sarcoma: In addition mRNA expression of SLC9A9 was reduced in MS subjects that experienced more relapses and a more activated lymphocyte profile and up-regulation of proinflammatory IFNγ in SLC9A9 knockdown polarized T helper cells in vitro.